Certified coders check every claim against the procedure note, including lesion size, margins, number of lesions and biopsy technique. Each billed code is supported by the documentation.
We confirm coverage, deductibles and referral requirements before the visit. That prevents front-end denials and surprise patient balances.
We submit and track authorizations for procedures, biologics and specialty drugs, including step-therapy documentation and renewals. Patients start treatment on time and therapy isn’t interrupted at renewal.
Claims are checked against NCCI edits and scrubbed for modifier 25 and 59 issues before submission. More claims are paid on the first pass.
We work every denial to its root cause and file appeals with supporting documentation. We also fix the upstream issue so it doesn’t repeat.
Unpaid and underpaid claims are chased by aging bucket until they are resolved. Your days in A/R stay low.
nsurance and patient payments are posted accurately and checked against contracted rates. Underpayments are flagged and your ledger matches your deposits.
Statements are clear and timely, with cosmetic and medical balances kept separate. Patients aren’t confused about what insurance covers and what they owe.
We handle applications, CAQH and payer enrollment so new providers can bill in-network without delays.
You get a monthly view of medical E/M, procedures, Mohs, pathology and cosmetic revenue. It shows where money is leaking and which service lines drive growth.
| CPT | Service | Watch-out |
|---|---|---|
| 99202–99215 | E/M visits | Add modifier 25 only when a significant, separately identifiable evaluation is documented apart from the procedure. |
| 11102–11107 | Skin biopsy by technique (tangential, punch, incisional) | Billed per lesion, with add-on codes for additional lesions. A lesion that is biopsied and then destroyed is bundled. |
| 17000, 17003, 17004 | Destruction of premalignant lesions (actinic keratoses) | 17000 is the first lesion, 17003 covers each additional lesion through 14, and 17004 is for 15 or more. |
| 17110, 17111 | Destruction of benign lesions (warts, molluscum) | 17110 covers up to 14 lesions and 17111 covers 15 or more; they are mutually exclusive. Skin tags are 11200 and 11201, not 17110. With 17000 on the same day, NCCI calls for modifier 59 or XS. |
| 11400–11446, 11600–11646 | Excision, benign and malignant | Size is the lesion diameter plus margins, measured before cutting. Measuring from the specimen or the pathology report under-bills. |
| 12001–13160, 14000–14302 | Repairs and flaps | Simple repair is included in the excision; intermediate and complex repairs and flaps are billed separately with layer and length documented. |
| 17311–17315 | Mohs micrographic surgery | Billed per stage and per tissue block. See the Mohs section below. |
| 88304, 88305, 88331 | Pathology and frozen section | The professional and technical split depends on who owns the lab and who reads the slide. |
| 96900, 96910–96913 | Phototherapy | Payers expect documented medical necessity and treatment details for each session. |
| 96920–96922 | Excimer laser for inflammatory skin disease | Billed by treatment area size in square centimeters. |
| 95044 | Patch testing | Billed per test applied, so units must match the record. |
| 11900, 11901 | Intralesional injection | Up to 7 lesions, or more than 7; the drug (for example triamcinolone, J3301) is billed separately. |
| 11200, 11201 | Skin tag removal | Often treated as cosmetic; document irritation, bleeding, or another medical reason. |
| Scenario | Typical Coding | Why |
|---|---|---|
| New rash is evaluated and a biopsy is taken at the same visit | E/M with modifier 25, plus the biopsy code | Separate evaluation of the rash, documented apart from the biopsy |
| Acne is managed and warts are destroyed at the same visit | E/M with modifier 25, plus 17110 | Two distinct conditions, each documented |
| Biopsy of one lesion, destruction of a different lesion | Both codes, with 59 or XS on the second code of the NCCI edit pair | Different lesions or sites; payers differ on which code carries the modifier |
| Biopsy and destruction of the same lesion | Destruction only | The biopsy is bundled into the destruction |
| Diagnostic biopsy before Mohs on the same lesion | Biopsy with 59 (or 58), plus the Mohs codes | CPT allows the biopsy to be reported separately |
| Routine skin check with cryotherapy of actinic keratoses and no separate problem | Procedure only | A separate E/M needs separate work documented |
Biologics for psoriasis, atopic dermatitis, and similar conditions (Dupixent and Cosentyx are common examples) carry more authorization work than any other dermatology service. We:
| Denial | Usual Cause | Fix |
|---|---|---|
| Modifier 25 denied | One blended note; the E/M cannot be seen apart from the procedure | Separate evaluation and procedure sections, plus a pre-bill check on every modifier 25 line |
| Biopsy or destruction bundled | Same lesion, or no 59 or XS on different lesions | Record the site of each lesion and apply the NCCI modifier only to separate lesions |
| Excision under-coded | Size taken from the specimen instead of lesion plus margins | Record diameter and margins before cutting |
| Mohs stage or repair denied | Stages or blocks lost; repair merged into the Mohs code | Keep a stage log during the case and code repair separately |
| Biologic claim denied | Authorization missing or expired, severity not documented | Track expiration dates and document severity scores |
| Cosmetic versus medical dispute | Service placed on the wrong side of the line | Decide at scheduling and apply the same-visit rule |
| Pathology paid wrong | Professional and technical components mixed up | One rule per specimen path |
By stage and tissue block: 17311 or 17313 for the first stage, 17312 or 17314 for each additional stage, and 17315 for each additional block after the first five. Reconstruction is billed separately.